A Population Study of Clinical Trial Accrual for Women and Minorities in Neuro-Oncology Following the NIH Revitalization Act
View ORCID ProfileSheantel J. Reihl, View ORCID ProfileNirav Patil, View ORCID ProfileRamin A. Morshed, Mulki Mehari, View ORCID ProfileAlexander Aabedi, Ugonma N. Chukwueke, View ORCID ProfileAlyx B. Porter, View ORCID ProfileValy Fontil, Gino Cioffi, Kristin Waite, Carol Kruchko, View ORCID ProfileQuinn Ostrom, Jill Barnholtz-Sloan, Shawn L. Hervey-Jumper
doi: https://doi.org/10.1101/2021.05.28.21258034
Sheantel J. Reihl
1University of California, San Francisco, Department of Neurosurgery, San Francisco, CA, U.S.A.
Nirav Patil
7Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, U.S.A.
8University Health System, Research and Education Institute, Cleveland, OH, U.S.A.
9University Hospitals Health System, Research Health Analytics and Informatics, Cleveland, OH, U.S.A.
Ramin A. Morshed
1University of California, San Francisco, Department of Neurosurgery, San Francisco, CA, U.S.A.
Mulki Mehari
1University of California, San Francisco, Department of Neurosurgery, San Francisco, CA, U.S.A.
Alexander Aabedi
1University of California, San Francisco, Department of Neurosurgery, San Francisco, CA, U.S.A.
Ugonma N. Chukwueke
2Center for Neuro-Oncology, Dana-Farber Cancer Institute, Department of Neurology, Harvard Medical School, Boston, MA, U.S.A.
Alyx B. Porter
3Mayo Clinic, Division of Neuro-Oncology, Department of Neurology, Phoenix, AZ, U.S.A.
Valy Fontil
4University of California San Francisco, Division of General Internal Medicine, San Francisco, California, U.S.A.
5University of California San Francisco, Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco, California, U.S.A.
Gino Cioffi
6Case Western Reserve University School of Medicine, Department of Population Health and Quantitative Sciences, Cleveland, OH, U.S.A.
Kristin Waite
6Case Western Reserve University School of Medicine, Department of Population Health and Quantitative Sciences, Cleveland, OH, U.S.A.
7Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, U.S.A.
10Cleveland Center for Health Outcomes Research (CCHOR), Cleveland, OH, U.S.A.
Carol Kruchko
7Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, U.S.A.
Quinn Ostrom
7Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, U.S.A.
12Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA
13The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, NC, USA
14Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA
Jill Barnholtz-Sloan
6Case Western Reserve University School of Medicine, Department of Population Health and Quantitative Sciences, Cleveland, OH, U.S.A.
7Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, U.S.A.
8University Health System, Research and Education Institute, Cleveland, OH, U.S.A.
9University Hospitals Health System, Research Health Analytics and Informatics, Cleveland, OH, U.S.A.
10Cleveland Center for Health Outcomes Research (CCHOR), Cleveland, OH, U.S.A.
11Case Comprehensive Cancer Center, Cleveland, OH, U.S.A.
Shawn L. Hervey-Jumper
1University of California, San Francisco, Department of Neurosurgery, San Francisco, CA, U.S.A.
Data Availability
All data used in this study are presented in the manuscript, supplemental data, and are available through review of published clinical trials on PubMed and/o ClinicalTrials.gov
Posted June 04, 2021.
A Population Study of Clinical Trial Accrual for Women and Minorities in Neuro-Oncology Following the NIH Revitalization Act
Sheantel J. Reihl, Nirav Patil, Ramin A. Morshed, Mulki Mehari, Alexander Aabedi, Ugonma N. Chukwueke, Alyx B. Porter, Valy Fontil, Gino Cioffi, Kristin Waite, Carol Kruchko, Quinn Ostrom, Jill Barnholtz-Sloan, Shawn L. Hervey-Jumper
medRxiv 2021.05.28.21258034; doi: https://doi.org/10.1101/2021.05.28.21258034
A Population Study of Clinical Trial Accrual for Women and Minorities in Neuro-Oncology Following the NIH Revitalization Act
Sheantel J. Reihl, Nirav Patil, Ramin A. Morshed, Mulki Mehari, Alexander Aabedi, Ugonma N. Chukwueke, Alyx B. Porter, Valy Fontil, Gino Cioffi, Kristin Waite, Carol Kruchko, Quinn Ostrom, Jill Barnholtz-Sloan, Shawn L. Hervey-Jumper
medRxiv 2021.05.28.21258034; doi: https://doi.org/10.1101/2021.05.28.21258034
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)